Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Processa Pharmaceuticals management to meet virtually with Benchmark » 04:55
04/21/21
04/21
04:55
04/21/21
04:55
PCSA

Processa Pharmaceuticals

$8.09 /

-0.77 (-8.69%)

Virtual Meeting to be…

Virtual Meeting to be held on April 21 hosted by Benchmark.

ShowHide Related Items >><<
PCSA Processa Pharmaceuticals
$8.09 /

-0.77 (-8.69%)

PCSA Processa Pharmaceuticals
$8.09 /

-0.77 (-8.69%)

12/08/20 Benchmark
Processa Pharmaceuticals initiated with a Speculative Buy at Benchmark
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Craig-Hallum
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum
Conference/Events
Processa Pharmaceuticals management to meet virtually with Benchmark » 09:45
04/20/21
04/20
09:45
04/20/21
09:45
PCSA

Processa Pharmaceuticals

$8.86 /

+ (+0.00%)

Virtual Meeting to be…

Virtual Meeting to be held on April 21 hosted by Benchmark.

ShowHide Related Items >><<
PCSA Processa Pharmaceuticals
$8.86 /

+ (+0.00%)

PCSA Processa Pharmaceuticals
$8.86 /

+ (+0.00%)

12/08/20 Benchmark
Processa Pharmaceuticals initiated with a Speculative Buy at Benchmark
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Craig-Hallum
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum
Over a month ago
Hot Stocks
Processa Pharmaceuticals selects sites for Phase 2b trial of PCS499 » 09:18
03/17/21
03/17
09:18
03/17/21
09:18
PCSA

Processa Pharmaceuticals

$11.86 /

+0.5 (+4.40%)

Processa Pharmaceuticals…

Processa Pharmaceuticals announces that it has selected 5 U.S. clinical sites to enroll patients with ulcerative necrobiosis lipoidica for the Company's Phase 2B trial "A Randomized, Double-blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PCS499 in Treating Ulcerations in Patients who Have Necrobiosis Lipoidica." Two to three additional clinical sites will be selected in the future including sites outside the U.S. Dr. Misha Rosenbach, Department of Dermatology at the University of Pennsylvania, is the Principal Investigator on the study. The study is expected to begin recruiting patients within the next 30-60 days.

ShowHide Related Items >><<
PCSA Processa Pharmaceuticals
$11.86 /

+0.5 (+4.40%)

PCSA Processa Pharmaceuticals
$11.86 /

+0.5 (+4.40%)

12/08/20 Benchmark
Processa Pharmaceuticals initiated with a Speculative Buy at Benchmark
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Craig-Hallum
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum
Hot Stocks
Processa Pharmaceuticals announces $10.2M strategic financing » 08:35
02/17/21
02/17
08:35
02/17/21
08:35
PCSA

Processa Pharmaceuticals

$8.05 /

-0.39 (-4.62%)

Processa Pharmaceuticals…

Processa Pharmaceuticals announced that it has executed a securities purchase agreement to raise gross proceeds of $10.2 million resulting from the sale of 1,321,132 shares through a private investment in public equity financing at a price of $7.75 per share. The financing attracted both institutional and accredited investors. The closing of the private placement is subject to the satisfaction of customary closing conditions, expected to occur on or about February 23, 2021. Tribal Capital Markets, LLC acted as sole placement agent for the offering. Allele Capital Partners, LLC through Tribal Capital Markets, LLC was responsible for sourcing and executing the offering.

ShowHide Related Items >><<
PCSA Processa Pharmaceuticals
$8.05 /

-0.39 (-4.62%)

PCSA Processa Pharmaceuticals
$8.05 /

-0.39 (-4.62%)

12/08/20 Benchmark
Processa Pharmaceuticals initiated with a Speculative Buy at Benchmark
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Craig-Hallum
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum
Over a quarter ago
Initiation
Processa Pharmaceuticals initiated with a Speculative Buy at Benchmark » 09:27
12/08/20
12/08
09:27
12/08/20
09:27
PCSA

Processa Pharmaceuticals

$7.45 /

+0.45 (+6.43%)

Benchmark analyst Aydin…

Benchmark analyst Aydin Huseynov initiated coverage of Processa Pharmaceuticals with a Speculative Buy rating and $15 price target. The company's eniluracil "probably can" reduce adverse events and improve efficacy of the current standard-of-care for multiple cancer indications, said Huseynov, who also thinks deuterated pentoxifylline may help patients with ulcerative Necrobiosis Lipoidica, which he notes is a skin disorder with no FDA-approved agents. While he assigns probability of success of 20% to Processa currently, Huseynov thinks the value of the company should "grow accordingly" as Processa moves forward in clinical development of its assets.

ShowHide Related Items >><<
PCSA Processa Pharmaceuticals
$7.45 /

+0.45 (+6.43%)

PCSA Processa Pharmaceuticals
$7.45 /

+0.45 (+6.43%)

10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Craig-Hallum
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum
Conference/Events
Craig-Hallum to hold a virtual conference » 09:15
11/17/20
11/17
09:15
11/17/20
09:15
ACMR

ACM Research

$81.36 /

-2.75 (-3.27%)

, CAMP

CalAmp

$8.72 /

+0.25 (+2.95%)

, CYBE

Cyberoptics

$25.54 /

+1.23 (+5.06%)

, EGAN

eGain

$11.25 /

-0.29 (-2.51%)

, HTGM

HTG Molecular

$0.28 /

-0.0163 (-5.57%)

, KRMD

Koru Medical

$4.18 /

+0.17 (+4.24%)

, MRNS

Marinus Pharmaceuticals

$14.01 /

-0.94 (-6.29%)

, PCSA

Processa Pharmaceuticals

$4.34 /

+0.03 (+0.70%)

, REPH

Recro Pharma

$1.96 /

+0.08 (+4.26%)

, SMTX

SMTC Corp.

$3.96 /

-0.1 (-2.46%)

, TPIC

TPI Composites

$39.98 /

+0.08 (+0.20%)

, WPRT

Westport

$2.93 /

+0.315 (+12.07%)

, SNBP

Sun BioPharma

$3.60 /

+0.09 (+2.56%)

, PEIX

Pacific Ethanol

$5.72 /

-0.015 (-0.26%)

, MSON

Misonix

$12.08 /

-0.11 (-0.90%)

, KRUS

Kura Sushi

$16.74 /

+0.54 (+3.33%)

, FLL

Full House Resorts

$3.44 /

+0.04 (+1.18%)

, FCEL

FuelCell

$3.75 /

+0.9 (+31.58%)

, TTEC

TTEC Holdings

$63.70 /

+1.26 (+2.02%)

, ZIXI

Zix

$6.87 /

+0.11 (+1.63%)

, SKY

Skyline Champion

$29.73 /

+0.73 (+2.52%)

, PAR

Par Technology

$50.51 /

+2.475 (+5.15%)

, CSBR

Champions Oncology

$12.22 /

+1.46 (+13.57%)

, HDSN

Hudson Technologies

$1.19 /

-0.03 (-2.47%)

, ITI

Iteris

$4.79 /

+0.22 (+4.81%)

, AMRC

Ameresco

$43.35 /

+0.21 (+0.49%)

, BWEN

Broadwind

$3.74 /

+0.215 (+6.10%)

11th Annual Alpha Select…

11th Annual Alpha Select Virtual Conference will be held on November 17.Webcast Link

ShowHide Related Items >><<
WPRT Westport
$2.93 /

+0.315 (+12.07%)

TTEC TTEC Holdings
$63.70 /

+1.26 (+2.02%)

TPIC TPI Composites
$39.98 /

+0.08 (+0.20%)

SMTX SMTC Corp.
$3.96 /

-0.1 (-2.46%)

PEIX Pacific Ethanol
$5.72 /

-0.015 (-0.26%)

PCSA Processa Pharmaceuticals
$4.34 /

+0.03 (+0.70%)

PAR Par Technology
$50.51 /

+2.475 (+5.15%)

MSON Misonix
$12.08 /

-0.11 (-0.90%)

MRNS Marinus Pharmaceuticals
$14.01 /

-0.94 (-6.29%)

KRMD Koru Medical
$4.18 /

+0.17 (+4.24%)

ITI Iteris
$4.79 /

+0.22 (+4.81%)

HTGM HTG Molecular
$0.28 /

-0.0163 (-5.57%)

HDSN Hudson Technologies
$1.19 /

-0.03 (-2.47%)

FLL Full House Resorts
$3.44 /

+0.04 (+1.18%)

FCEL FuelCell
$3.75 /

+0.9 (+31.58%)

EGAN eGain
$11.25 /

-0.29 (-2.51%)

CAMP CalAmp
$8.72 /

+0.25 (+2.95%)

BWEN Broadwind
$3.74 /

+0.215 (+6.10%)

AMRC Ameresco
$43.35 /

+0.21 (+0.49%)

ACMR ACM Research
$81.36 /

-2.75 (-3.27%)

ACMR ACM Research
$81.36 /

-2.75 (-3.27%)

10/27/20 Jefferies
ACM Research initiated with a Buy at Jefferies
10/09/20 Stifel
Short report on ACM Research 'misleading' and 'erroneous,' says Stifel
10/01/20 Roth Capital
Roth Capital encouraged by milestone in ACM Research's STAR Market IPO plan
09/11/20 Stifel
Stifel upgrades ACM Research to Buy after 'overdone' pullback
CAMP CalAmp
$8.72 /

+0.25 (+2.95%)

09/25/20 Jefferies
CalAmp shares should re-rate higher as recurring revenue grows, says Jefferies
04/17/20 Jefferies
CalAmp upgraded to Buy at Jefferies with downside case seen as priced in
04/17/20 Jefferies
CalAmp upgraded to Buy from Hold at Jefferies
03/26/20 JPMorgan
CalAmp price target lowered to $9 from $12 at JPMorgan
CYBE Cyberoptics
$25.54 /

+1.23 (+5.06%)

10/26/20 Colliers
Cyberoptics initiated with a Buy at Colliers
06/18/20 Craig-Hallum
Cyberoptics price target raised to $43 from $33 at Craig-Hallum
06/09/20
Cyberoptics downgraded to Neutral from Buy at Dougherty
04/24/20 Lake Street
Cyberoptics investors to be pleased with 'impressive' guidance, says Lake Street
EGAN eGain
$11.25 /

-0.29 (-2.51%)

10/20/20 Berenberg
eGain initiated with a Buy at Berenberg
10/14/20 Benchmark
eGain share price may be benefiting from M&A speculation, says Benchmark
09/09/20
Fly Intel: Top five analyst initiations
09/09/20 DA Davidson
eGain initiated with a Buy at DA Davidson
HTGM HTG Molecular
$0.28 /

-0.0163 (-5.57%)

06/04/20 Cantor Fitzgerald
HTG Molecular case study to be used as marketing, says Cantor Fitzgerald
05/11/20 Cantor Fitzgerald
HTG Molecular assumed with an Overweight at Cantor Fitzgerald
03/26/20 Craig-Hallum
HTG Molecular downgraded to Hold from Buy at Craig-Hallum
KRMD Koru Medical
$4.18 /

+0.17 (+4.24%)

11/04/20 Piper Sandler
Koru Medical earnings selloff a buying opportunity, says Piper Sandler
08/10/20 H.C. Wainwright
KORU Medical Systems initiated with a Buy at H.C. Wainwright
08/05/20 Piper Sandler
KORU Medical Systems price target raised to $14 from $12 at Piper Sandler
07/16/20 Canaccord
KORU Medical Systems initiated with a Buy at Canaccord
MRNS Marinus Pharmaceuticals
$14.01 /

-0.94 (-6.29%)

11/10/20 Cantor Fitzgerald
Marinus Pharmaceuticals price target raised to $27 from $8 at Cantor Fitzgerald
09/30/20 Truist
Marinus Pharmaceuticals initiated with a Buy at Truist
09/25/20 JMP Securities
Marinus Pharmaceuticals price target raised to $26 from $7 at JMP Securities
09/23/20 Oppenheimer
Marinus Pharmaceuticals price target raised to $28 from $7 at Oppenheimer
PCSA Processa Pharmaceuticals
$4.34 /

+0.03 (+0.70%)

10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Craig-Hallum
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum
REPH Recro Pharma
$1.96 /

+0.08 (+4.26%)

05/12/20 Oppenheimer
Recro Pharma price target lowered to $12 from $18 at Oppenheimer
SMTX SMTC Corp.
$3.96 /

-0.1 (-2.46%)

11/05/20 B. Riley
SMTC Corp. price target raised to $7 from $6 at B. Riley Securities
TPIC TPI Composites
$39.98 /

+0.08 (+0.20%)

11/09/20 Roth Capital
TPI Composites price target raised to $48 from $40 at Roth Capital
10/21/20 Morgan Stanley
TPI Composites assumed with an Overweight at Morgan Stanley
10/12/20 BTIG
TPI Composites price target raised to $42 from $30 at BTIG
10/09/20 Roth Capital
Roth Capital sees positive outcome for Workhorse in USPS contract
WPRT Westport
$2.93 /

+0.315 (+12.07%)

09/18/20 Craig-Hallum
Westport's China opportunity 'not close to being reflected,' says Craig-Hallum
07/24/20 Lake Street
Westport convertible debt restructuring removes overhang, says Lake Street
06/05/20 Lake Street
Lake Street says Westport liquidity issues addressed, should see strong recovery
03/18/20 Lake Street
Westport price target lowered to $4 from $5 at Lake Street
SNBP Sun BioPharma
$3.60 /

+0.09 (+2.56%)

09/28/20 Craig-Hallum
Craig-Hallum bullish on Sun BioPharma, initiates with a Buy
09/28/20 Craig-Hallum
Sun BioPharma initiated with a Buy at Craig-Hallum
PEIX Pacific Ethanol
$5.72 /

-0.015 (-0.26%)

09/29/20 Craig-Hallum
Pacific Ethanol price target raised to $13 from $9 at Craig-Hallum
09/22/20 BWS Financial
Pacific Ethanol initiated with a Buy at BWS Financial
09/16/20 H.C. Wainwright
Pacific Ethanol price target raised to $16 from $3 at H.C. Wainwright
MSON Misonix
$12.08 /

-0.11 (-0.90%)

07/13/20 Craig-Hallum
Misonix price target raised to $23 from $18 at Craig-Hallum
04/03/20 Craig-Hallum
Misonix price target lowered to $18 from $28 at Craig-Hallum
04/03/20 BTIG
Misonix price target lowered to $18 from $27 at BTIG
12/31/19 Craig-Hallum
Misonix's amended credit line removes capital needs questions, says Craig-Hallum
KRUS Kura Sushi
$16.74 /

+0.54 (+3.33%)

11/16/20 Craig-Hallum
Kura Sushi price target raised to $17 from $11 at Craig-Hallum
10/06/20 Daiwa
Kura Sushi initiated with an Outperform at Daiwa
07/15/20 BTIG
Kura Sushi price target lowered to $20 from $30 at BTIG
07/15/20 Craig-Hallum
Kura Sushi price target lowered to $11 from $16 at Craig-Hallum
FLL Full House Resorts
$3.44 /

+0.04 (+1.18%)

10/15/20
Fly Intel: Pre-market Movers
10/15/20 Craig-Hallum
Full House Resorts initiated with a Buy at Craig-Hallum
05/14/20 Roth Capital
Full House Resorts 'significantly undervalued,' says Roth Capital
FCEL FuelCell
$3.75 /

+0.9 (+31.58%)

10/08/20
Fly Intel: Top five analyst initiations
10/08/20 JPMorgan
FuelCell initiated with an Overweight at JPMorgan
06/15/20
Fly Intel: Top five analyst downgrades
06/15/20 Craig-Hallum
FuelCell downgraded to Sell at Craig-Hallum
TTEC TTEC Holdings
$63.70 /

+1.26 (+2.02%)

10/15/20 Canaccord
TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
10/15/20 Canaccord
TTEC Holdings initiated with a Buy at Canaccord
08/10/20
Fly Intel: Top five analyst downgrades
08/10/20 Sidoti
TTEC Holdings downgraded to Neutral from Buy at Sidoti
ZIXI Zix
$6.87 /

+0.11 (+1.63%)

06/29/20 Northland
Zix price target raised to $11 from $9 at Northland
03/31/20 Northland
Zix debt covenant concerns unfounded, says Northland
03/27/20 Craig-Hallum
Zix assumed with a Buy at Craig-Hallum
SKY Skyline Champion
$29.73 /

+0.73 (+2.52%)

05/21/20 Truist
Skyline upgraded to Buy from Hold at SunTrust
05/20/20 Truist
SunTrust upgrades Skyline to Buy ahead of today's earnings report
05/20/20 Truist
Skyline upgraded to Buy from Hold at SunTrust
04/07/20 RBC Capital
Skyline downgraded to Sector Perform from Outperform at RBC Capital
PAR Par Technology
$50.51 /

+2.475 (+5.15%)

11/09/20
Fly Intel: Top five analyst downgrades
11/09/20 Roth Capital
Par Technology downgraded to Neutral from Buy at Roth Capital
11/09/20 Craig-Hallum
Par Technology price target raised to $55 from $50 at Craig-Hallum
11/08/20 BTIG
Par Technology price target raised to $55 from $50 at BTIG
CSBR Champions Oncology
$12.22 /

+1.46 (+13.57%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
11/18/19
Fly Intel: Top five analyst initiations
11/18/19 Benchmark
Champions Oncology initiated with a Speculative Buy at Benchmark
HDSN Hudson Technologies
$1.19 /

-0.03 (-2.47%)

ITI Iteris
$4.79 /

+0.22 (+4.81%)

AMRC Ameresco
$43.35 /

+0.21 (+0.49%)

11/03/20 Craig-Hallum
Ameresco price target raised to $50 from $38 at Craig-Hallum
11/03/20 B. Riley
Ameresco price target raised to $50 from $48 at B. Riley Securities
11/03/20 Oppenheimer
Ameresco price target raised to $43 from $33 at Oppenheimer
10/27/20 B. Riley
Ameresco price target raised to $48 from $33 at B. Riley Securities
BWEN Broadwind
$3.74 /

+0.215 (+6.10%)

09/09/20 Johnson Rice
Broadwind initiated with a Buy at Johnson Rice
07/22/20 H.C. Wainwright
Wind 'a big beneficiary' in NY renewable energy expansion, says H.C. Wainwright
07/07/20 Craig-Hallum
Broadwind initiated with a Buy at Craig-Hallum
06/16/20 H.C. Wainwright
Broadwind initiated with a Buy at H.C. Wainwright
ZIXI Zix
$6.87 /

+0.11 (+1.63%)

WPRT Westport
$2.93 /

+0.315 (+12.07%)

TTEC TTEC Holdings
$63.70 /

+1.26 (+2.02%)

TPIC TPI Composites
$39.98 /

+0.08 (+0.20%)

SKY Skyline Champion
$29.73 /

+0.73 (+2.52%)

REPH Recro Pharma
$1.96 /

+0.08 (+4.26%)

PEIX Pacific Ethanol
$5.72 /

-0.015 (-0.26%)

PAR Par Technology
$50.51 /

+2.475 (+5.15%)

MSON Misonix
$12.08 /

-0.11 (-0.90%)

MRNS Marinus Pharmaceuticals
$14.01 /

-0.94 (-6.29%)

KRUS Kura Sushi
$16.74 /

+0.54 (+3.33%)

KRMD Koru Medical
$4.18 /

+0.17 (+4.24%)

ITI Iteris
$4.79 /

+0.22 (+4.81%)

HTGM HTG Molecular
$0.28 /

-0.0163 (-5.57%)

FLL Full House Resorts
$3.44 /

+0.04 (+1.18%)

FCEL FuelCell
$3.75 /

+0.9 (+31.58%)

EGAN eGain
$11.25 /

-0.29 (-2.51%)

CYBE Cyberoptics
$25.54 /

+1.23 (+5.06%)

CAMP CalAmp
$8.72 /

+0.25 (+2.95%)

BWEN Broadwind
$3.74 /

+0.215 (+6.10%)

AMRC Ameresco
$43.35 /

+0.21 (+0.49%)

ACMR ACM Research
$81.36 /

-2.75 (-3.27%)

  • 01
    Oct
  • 30
    Sep
  • 19
    Jun
  • 29
    May
  • 23
    Jan
  • 11
    Dec
  • 06
    Dec
BWEN Broadwind
$3.74 /

+0.215 (+6.10%)

ACMR ACM Research
$81.36 /

-2.75 (-3.27%)

ZIXI Zix
$6.87 /

+0.11 (+1.63%)

TPIC TPI Composites
$39.98 /

+0.08 (+0.20%)

SNBP Sun BioPharma
$3.60 /

+0.09 (+2.56%)

SKY Skyline Champion
$29.73 /

+0.73 (+2.52%)

PAR Par Technology
$50.51 /

+2.475 (+5.15%)

MRNS Marinus Pharmaceuticals
$14.01 /

-0.94 (-6.29%)

KRUS Kura Sushi
$16.74 /

+0.54 (+3.33%)

KRMD Koru Medical
$4.18 /

+0.17 (+4.24%)

ITI Iteris
$4.79 /

+0.22 (+4.81%)

FCEL FuelCell
$3.75 /

+0.9 (+31.58%)

EGAN eGain
$11.25 /

-0.29 (-2.51%)

CYBE Cyberoptics
$25.54 /

+1.23 (+5.06%)

CAMP CalAmp
$8.72 /

+0.25 (+2.95%)

BWEN Broadwind
$3.74 /

+0.215 (+6.10%)

ACMR ACM Research
$81.36 /

-2.75 (-3.27%)

WPRT Westport
$2.93 /

+0.315 (+12.07%)

PEIX Pacific Ethanol
$5.72 /

-0.015 (-0.26%)

MRNS Marinus Pharmaceuticals
$14.01 /

-0.94 (-6.29%)

KRMD Koru Medical
$4.18 /

+0.17 (+4.24%)

FCEL FuelCell
$3.75 /

+0.9 (+31.58%)

CYBE Cyberoptics
$25.54 /

+1.23 (+5.06%)

CAMP CalAmp
$8.72 /

+0.25 (+2.95%)

Initiation
Fly Intel: Top five analyst initiations » 09:52
10/28/20
10/28
09:52
10/28/20
09:52
CALM

Cal-Maine Foods

$39.15 /

+0.3 (+0.77%)

, BURL

Burlington Stores

$197.66 /

-2.83 (-1.41%)

, RPTX

Repare Therapeutics

$26.32 /

-0.13 (-0.49%)

, PCSA

Processa Pharmaceuticals

$4.22 /

+ (+0.00%)

, HYLN

Hyliion Holdings

$20.17 /

-1.08 (-5.08%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cal-Maine Foods (CALM) initiated with a Buy at BofA. 2. Burlington Stores (BURL) initiated with a Buy at Jefferies. 3. Repare Therapeutics (RPTX) initiated with an Outperform at Northland. 4. Processa Pharmaceuticals (PCSA) initiated with a Buy at Craig-Hallum. 5. Hyliion Holdings (HYLN) initiated with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RPTX Repare Therapeutics
$26.32 /

-0.13 (-0.49%)

PCSA Processa Pharmaceuticals
$4.22 /

+ (+0.00%)

HYLN Hyliion Holdings
$20.17 /

-1.08 (-5.08%)

CALM Cal-Maine Foods
$39.15 /

+0.3 (+0.77%)

BURL Burlington Stores
$197.66 /

-2.83 (-1.41%)

CALM Cal-Maine Foods
$39.15 /

+0.3 (+0.77%)

10/28/20 BofA
Cal-Maine Foods initiated with a Buy at BofA
10/28/20 BofA
Cal-Maine Foods initiated with a Buy at BofA
03/31/20 Goldman Sachs
Cal-Maine's near-term demand strength unsustainable, says Goldman Sachs
03/17/20 Stephens
Cal-Maine Foods upgraded to Overweight at Stephens
BURL Burlington Stores
$197.66 /

-2.83 (-1.41%)

10/28/20 Jefferies
Burlington Stores initiated with a Buy at Jefferies
10/27/20 Berenberg
Burlington Stores initiated with a Buy at Berenberg
10/07/20 Barclays
Burlington Stores price target raised to $246 from $238 at Barclays
10/01/20 Loop Capital
Burlington Stores price target raised to $240 from $225 at Loop Capital
RPTX Repare Therapeutics
$26.32 /

-0.13 (-0.49%)

10/28/20 Northland
Repare Therapeutics initiated with an Outperform at Northland
09/25/20 Piper Sandler
Repare Therapeutics viewed as core long-term holding at Piper Sandler
07/14/20
Fly Intel: Top five analyst initiations
07/14/20 Morgan Stanley
Repare Therapeutics initiated with an Overweight at Morgan Stanley
PCSA Processa Pharmaceuticals
$4.22 /

+ (+0.00%)

10/28/20 Craig-Hallum
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum
HYLN Hyliion Holdings
$20.17 /

-1.08 (-5.08%)

10/28/20 JPMorgan
Hyliion Holdings initiated with a Neutral at JPMorgan
10/15/20 Goldman Sachs
Hyliion Holdings initiated with a Neutral at Goldman Sachs
RPTX Repare Therapeutics
$26.32 /

-0.13 (-0.49%)

CALM Cal-Maine Foods
$39.15 /

+0.3 (+0.77%)

BURL Burlington Stores
$197.66 /

-2.83 (-1.41%)

  • 20
    Aug
  • 19
    Jun
HYLN Hyliion Holdings
$20.17 /

-1.08 (-5.08%)

RPTX Repare Therapeutics
$26.32 /

-0.13 (-0.49%)

CALM Cal-Maine Foods
$39.15 /

+0.3 (+0.77%)

BURL Burlington Stores
$197.66 /

-2.83 (-1.41%)

HYLN Hyliion Holdings
$20.17 /

-1.08 (-5.08%)

BURL Burlington Stores
$197.66 /

-2.83 (-1.41%)

Initiation
Processa Pharmaceuticals initiated with a Buy at Craig-Hallum » 09:03
10/28/20
10/28
09:03
10/28/20
09:03
PCSA

Processa Pharmaceuticals

$4.22 /

+0.06 (+1.44%)

Craig-Hallum analyst…

Craig-Hallum analyst Robin Garner initiated coverage of Processa Pharmaceuticals with a Buy rating and $12 price target. The analyst believes the current market cap of $30M does not seem to incorporate the cash balance and 3 clinical programs that each address billion-plus dollar markets. Processa Pharmaceuticals has meticulously built a portfolio with high potential returns by inexpensively in-licensing assets with evidence of clinical efficacy and improvement on existing therapies and identifying cost-efficient paths for approval, he contends.

ShowHide Related Items >><<
PCSA Processa Pharmaceuticals
$4.22 /

+0.06 (+1.44%)

Hot Stocks
Processa Pharmaceuticals appoints Michael Floyd as COO » 09:38
10/13/20
10/13
09:38
10/13/20
09:38
PCSA

Processa Pharmaceuticals

$4.80 /

+0.1 (+2.13%)

Processa Pharmaceuticals…

Processa Pharmaceuticals announced the appointment of Michael Floyd as the Company's Chief Operating Officer. Mr. Floyd is a serial entrepreneur who, over the last 15 years, has formed and been a senior executive in several life science organizations focused on the development of products to treat infectious and rare diseases, as well as the development of oncology drugs. He founded the early stage enterprise Neurologic, that in-licensed technology from the NIH for a diagnostic test for Alzheimer's disease.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.